We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
-16.98%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$4.68B
AUM Growth
-$1.71B
Cap. Flow
-$462M
Cap. Flow %
-9.88%
Top 10 Hldgs %
25.31%
Holding
149
New
16
Increased
23
Reduced
54
Closed
13

Top Buys

Rank Stock Value
1
DOCS icon
Doximity
DOCS
+$59.6M
2
GTM
ZoomInfo Technologies
GTM
+$19.8M
3
CMS icon
CMS Energy
CMS
+$19.8M
4
GH icon
Guardant Health
GH
+$18.2M
5
LNG icon
Cheniere Energy
LNG
+$15.6M

Top Sells

Rank Stock Value
1
DT icon
Dynatrace
DT
+$112M
2
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$64.6M
3
SMAR
Smartsheet Inc.
SMAR
+$38.2M
4
ROP icon
Roper Technologies
ROP
+$32.9M
5
LRCX icon
Lam Research
LRCX
+$31.8M

Sector Composition

Rank Sector Weight
1 Healthcare 35.3%
2 Technology 26.13%
3 Industrials 16.22%
4 Consumer Discretionary 5.49%
5 Utilities 5.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENPH icon
51
Enphase Energy
ENPH
$4.94B
$31.8M 0.68%
163,000
+18,931
+13% +$3.42M
LSCC icon
52
Lattice Semiconductor
LSCC
$17.7B
$31.6M 0.67%
650,544
+178,800
+38% +$8.9M
HASI icon
53
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.85B
$31.1M 0.67%
822,664
-87,800
-10% -$3.49M
MASS icon
54
908 Devices
MASS
$313M
$30.8M 0.66%
1,498,101
+88,101
+6% +$1.48M
CWEN icon
55
Clearway Energy Class C
CWEN
$4.94B
$29.3M 0.63%
842,400
-687,400
-45% -$23.1M
REXR icon
56
Rexford Industrial Realty
REXR
$8.56B
$28.9M 0.62%
501,293
-95,707
-16% -$6.57M
ZYME icon
57
Zymeworks
ZYME
$1.67B
$28.5M 0.61%
5,380,200
– –
ZNTL icon
58
Zentalis Pharmaceuticals
ZNTL
$350M
$28.2M 0.6%
1,004,000
+243,000
+32% +$6.44M
BEPC icon
59
Brookfield Renewable
BEPC
$6.04B
$27.6M 0.59%
775,019
– –
VRSK icon
60
Verisk Analytics
VRSK
$26.1B
$27.3M 0.58%
157,800
-7,300
-4% -$1.36M
NVT icon
61
nVent Electric
NVT
$23.4B
$26.9M 0.58%
859,200
-23,400
-3% -$798K
STE icon
62
Steris
STE
$22.5B
$23.1M 0.49%
112,185
– –
NBIX icon
63
Neurocrine Biosciences
NBIX
$18.7B
$22.9M 0.49%
235,000
– –
WMB icon
64
Williams Companies
WMB
$86.7B
$22.4M 0.48%
717,700
+63,600
+10% +$2.2M
MDB icon
65
MongoDB
MDB
$26.2B
$22.3M 0.48%
86,000
-3,355
-4% -$1.05M
BPMC
66
DELISTED
Blueprint Medicines
BPMC
$22.1M 0.47%
438,500
-154,000
-26% -$9.02M
IMVT icon
67
Immunovant
IMVT
$8.11B
$21M 0.45%
5,372,512
– –
DICE
68
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$20.8M 0.44%
1,370,261
-501,351
-27% -$8.62M
CMS icon
69
CMS Energy
CMS
$22.7B
$19.4M 0.41%
+286,800
New +$19.8M
RGEN icon
70
Repligen
RGEN
$7.03B
$19.3M 0.41%
119,000
– –
WEC icon
71
WEC Energy
WEC
$35.8B
$19.3M 0.41%
192,000
+46,600
+32% +$4.72M
NDAQ icon
72
Nasdaq
NDAQ
$53.2B
$18.3M 0.39%
359,700
-12,300
-3% -$651K
FRC
73
DELISTED
First Republic Bank
FRC
$18.2M 0.39%
126,400
+18,000
+17% +$2.7M
CCXI
74
DELISTED
ChemoCentryx, Inc.
CCXI
$18M 0.39%
728,385
– –
ESI icon
75
Element Solutions
ESI
$8.68B
$17.3M 0.37%
971,000
– –
1 2
3
4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q2 2022 Portfolio in Review

As of Q2 2022, Eventide Asset Management held 149 positions worth $4.68B, down 27% from $6.38B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Eventide Asset Management withdrew a net $462M in Q2 2022, closing 13 positions and reducing 54 holdings. Its most notable exit was Dynatrace, an estimated $112M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Technology and Industrials.

Against the trend, Eventide Asset Management opened a new position in Doximity worth $52.7M.

  • Eventide Asset Management's largest Q2 2022 buy was Doximity: 1,512,602 shares worth $52.7M.
  • Eventide Asset Management added most to ZoomInfo Technologies in Q2 2022, an estimated $19.8M increase.
  • Eventide Asset Management's biggest Q2 2022 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $64.6M.
  • Eventide Asset Management fully exited Dynatrace in Q2 2022, selling an estimated $112M.
  • Eventide Asset Management's ten largest holdings make up 25% of its $4.68B portfolio in Q2 2022.
  • Eventide Asset Management opened 16 new positions and closed 13 in Q2 2022.
  • Eventide Asset Management's portfolio value fell 27% quarter-over-quarter to $4.68B.

Based on Eventide Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.